DelphX Pfcf Ratio vs Price To Sales Ratio Analysis
DELX Stock | CAD 0.11 0.01 10.00% |
DelphX Capital financial indicator trend analysis is much more than just examining DelphX Capital Markets latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DelphX Capital Markets is a good investment. Please check the relationship between DelphX Capital Pfcf Ratio and its Price To Sales Ratio accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DelphX Capital Markets. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Pfcf Ratio vs Price To Sales Ratio
Pfcf Ratio vs Price To Sales Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DelphX Capital Markets Pfcf Ratio account and Price To Sales Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between DelphX Capital's Pfcf Ratio and Price To Sales Ratio is -0.38. Overlapping area represents the amount of variation of Pfcf Ratio that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of DelphX Capital Markets, assuming nothing else is changed. The correlation between historical values of DelphX Capital's Pfcf Ratio and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pfcf Ratio of DelphX Capital Markets are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Pfcf Ratio i.e., DelphX Capital's Pfcf Ratio and Price To Sales Ratio go up and down completely randomly.
Correlation Coefficient | -0.38 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Pfcf Ratio
Price To Sales Ratio
Price to Sales Ratio is figured by comparing DelphX Capital Markets stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on DelphX Capital sales, a figure that is much harder to manipulate than other DelphX Capital Markets multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Most indicators from DelphX Capital's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DelphX Capital Markets current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DelphX Capital Markets. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. At this time, DelphX Capital's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 46.53 in 2024, whereas Sales General And Administrative To Revenue is likely to drop (139.06) in 2024.
DelphX Capital fundamental ratios Correlations
Click cells to compare fundamentals
DelphX Capital Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DelphX Capital fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 624.0K | 545.9K | 1.8M | 475.2K | 237.1K | 225.2K | |
Total Current Liabilities | 2.2M | 4.5M | 2.8M | 3.4M | 2.6M | 2.3M | |
Total Stockholder Equity | (2.6M) | (4.1M) | (1.0M) | (2.9M) | (2.4M) | (2.5M) | |
Net Tangible Assets | 406.6K | (713.8K) | (2.6M) | (4.1M) | (3.7M) | (3.5M) | |
Net Debt | 926.9K | 844.1K | (1.3M) | (263.6K) | (237.2K) | (225.4K) | |
Retained Earnings | (22.1M) | (24.7M) | (27.9M) | (32.6M) | (34.6M) | (32.9M) | |
Accounts Payable | 1.3M | 1.3M | 2.6M | 3.4M | 2.6M | 1.7M | |
Cash | 135.6K | 181.7K | 1.5M | 263.6K | 136.2K | 129.4K | |
Non Currrent Assets Other | 287.8K | (354.6K) | (248.2K) | (141.8K) | (127.7K) | (121.3K) | |
Cash And Short Term Investments | 135.6K | 181.7K | 1.5M | 263.6K | 303.1K | 395.6K | |
Liabilities And Stockholders Equity | 624.0K | 545.9K | 1.8M | 475.2K | 546.5K | 700.5K | |
Other Stockholder Equity | 2.2M | 2.8M | 6.0M | 4.8M | 5.6M | 5.8M | |
Total Liab | 3.2M | 4.6M | 2.8M | 3.4M | 2.6M | 2.5M | |
Total Current Assets | 269.4K | 297.7K | 1.7M | 475.2K | 237.1K | 225.2K | |
Common Stock | 17.1M | 17.5M | 20.6M | 22.7M | 26.1M | 14.8M | |
Property Plant Equipment | 1.3K | 170.5K | 354.6K | 248.2K | 285.5K | 170.9K | |
Other Current Liab | 870.8K | 2.3M | 66.7K | 135.0 | 121.5 | 115.43 | |
Common Stock Shares Outstanding | 85.4M | 93.2M | 119.0M | 133.5M | 150.8M | 103.4M | |
Other Current Assets | 24.1K | 36.2K | 132.2K | 54.0K | 48.6K | 46.2K | |
Net Invested Capital | (1.9M) | (3.4M) | (1.0M) | (2.9M) | (2.4M) | (2.5M) | |
Accumulated Other Comprehensive Income | 177.5K | 324.7K | 332.0K | 2.1M | 2.5M | 2.6M | |
Net Working Capital | (2.0M) | (4.2M) | (1.1M) | (2.9M) | (2.4M) | (2.5M) | |
Net Receivables | 82.2K | 79.7K | 59.8K | 157.6K | 181.2K | 114.9K | |
Capital Stock | 17.1M | 17.5M | 20.6M | 22.7M | 24.4M | 21.7M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for DelphX Stock Analysis
When running DelphX Capital's price analysis, check to measure DelphX Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DelphX Capital is operating at the current time. Most of DelphX Capital's value examination focuses on studying past and present price action to predict the probability of DelphX Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DelphX Capital's price. Additionally, you may evaluate how the addition of DelphX Capital to your portfolios can decrease your overall portfolio volatility.